These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32589563)

  • 21. Assessment of protective role of polyherbal preparation, Livina, against anti-tubercular drug induced liver dysfunction.
    Gulati K; Ray A; Vijayan VK
    Indian J Exp Biol; 2010 Mar; 48(3):318-22. PubMed ID: 21046988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug-induced hepatotoxicity and tuberculosis in a hospital from the Argentinian northeast: cross-sectional study.
    Golemba AS; Ferreyra FG; Martearena RE; Achinelli FR; Rovai GB
    Medwave; 2015 May; 15(4):e6135. PubMed ID: 26035138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adherence to nine-month isoniazid for latent tuberculosis infection in healthcare workers: a prospective study in a tertiary hospital.
    Chung SJ; Lee H; Koo GW; Min JH; Yeo Y; Park DW; Park TS; Moon JY; Kim SH; Kim TH; Sohn JW; Yoon HJ
    Sci Rep; 2020 Apr; 10(1):6462. PubMed ID: 32296096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-TB drug concentrations and drug-associated toxicities among TB/HIV-coinfected patients.
    Sekaggya-Wiltshire C; von Braun A; Scherrer AU; Manabe YC; Buzibye A; Muller D; Ledergerber B; Gutteck U; Corti N; Kambugu A; Byakika-Kibwika P; Lamorde M; Castelnuovo B; Fehr J; Kamya MR
    J Antimicrob Chemother; 2017 Apr; 72(4):1172-1177. PubMed ID: 28108678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alanine transaminase and hemoglobin appear to predict the occurrence of antituberculosis medication hepatotoxicity; findings and implications in Botswana.
    Kesenogile B; Godman B; Rwegerera GM
    Expert Rev Anti Infect Ther; 2021 Mar; 19(3):379-391. PubMed ID: 32909487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatotoxicity induced by antituberculosis drugs among patients coinfected with HIV and tuberculosis.
    Lima Mde F; Melo HR
    Cad Saude Publica; 2012 Apr; 28(4):698-708. PubMed ID: 22488315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk assessment of hepatotoxicity among tuberculosis and human immunodeficiency virus/AIDS-coinfected patients under tuberculosis treatment.
    Ngouleun W; Biapa Nya PC; Pieme AC; Telefo PB
    Int J Mycobacteriol; 2016 Dec; 5(4):482-488. PubMed ID: 27931691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatotoxicity due to antituberculosis therapy. Clinical profile and reintroduction of therapy.
    Singh J; Garg PK; Tandon RK
    J Clin Gastroenterol; 1996 Apr; 22(3):211-4. PubMed ID: 8724260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-induced liver injury from antituberculous treatment: a retrospective study from a large TB centre in the UK.
    Abbara A; Chitty S; Roe JK; Ghani R; Collin SM; Ritchie A; Kon OM; Dzvova J; Davidson H; Edwards TE; Hateley C; Routledge M; Buckley J; Davidson RN; John L
    BMC Infect Dis; 2017 Mar; 17(1):231. PubMed ID: 28340562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First line anti-tuberculosis induced hepatotoxicity: incidence and risk factors.
    Bouazzi OE; Hammi S; Bourkadi JE; Tebaa A; Tanani DS; Soulaymani-Bencheikh R; Badrane N; Bengueddour R
    Pan Afr Med J; 2016; 25():167. PubMed ID: 28292129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatotoxicity in HIV Patients, An Observational Study in Patients from Tertiary Care Centre of Western India.
    Bajpai S; Joshi K
    J Assoc Physicians India; 2017 May; 65(5):47-49. PubMed ID: 28598048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence, clinical features and impact on anti-tuberculosis treatment of anti-tuberculosis drug induced liver injury (ATLI) in China.
    Shang P; Xia Y; Liu F; Wang X; Yuan Y; Hu D; Tu D; Chen Y; Deng P; Cheng S; Zhou L; Ma Y; Zhu L; Gao W; Wang H; Chen D; Yang L; He P; Wu S; Tang S; Lv X; Shu Z; Zhang Y; Yang Z; Chen Y; Li N; Sun F; Li X; He Y; Garner P; Zhan S
    PLoS One; 2011; 6(7):e21836. PubMed ID: 21750735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequency of anti-tuberculous therapy-induced hepatotoxicity in patients and their outcome.
    Tariq S; Khan TS; Malik S; Anwar MS; Rashid A
    J Ayub Med Coll Abbottabad; 2009; 21(4):50-2. PubMed ID: 21067024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Common risk factors for the development of anti tuberculosis treatment induced hepatotoxicity.
    Abbasi MA; Ahmed N; Suleman A; Zaman H; Tariq S; Anwar SA; Khan N
    J Ayub Med Coll Abbottabad; 2014; 26(3):384-8. PubMed ID: 25671954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors associated with anti-TB drug-induced hepatotoxicity and genetic polymorphisms in indigenous and non-indigenous populations in Brazil.
    Heinrich MM; Zembrzuski VM; Ota MM; Sacchi FP; Teixeira RL; Cabello Acero PH; Cunha GM; Souza-Santos R; Croda J; Basta PC
    Tuberculosis (Edinb); 2016 Dec; 101():15-24. PubMed ID: 27865386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B or hepatitis C co-infection in individuals infected with human immunodeficiency virus and effect of anti-tuberculosis drugs on liver function.
    Padmapriyadarsini C; Chandrabose J; Victor L; Hanna LE; Arunkumar N; Swaminathan S
    J Postgrad Med; 2006; 52(2):92-6. PubMed ID: 16679670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatotoxicity during TB treatment in people with HIV/AIDS related to NAT2 polymorphisms in Pernambuco, Northeast Brazil.
    Araujo-Mariz C; Militão de Albuquerque MFP; Lopes EP; Ximenes RAA; Lacerda HR; Miranda-Filho DB; Lustosa-Martins BB; Pastor AFP; Acioli-Santos B
    Ann Hepatol; 2020; 19(2):153-160. PubMed ID: 31734174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatotoxicity in patients co-infected with tuberculosis and HIV-1 while receiving non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy and rifampicin-containing anti-tuberculosis regimen.
    Mankhatitham W; Lueangniyomkul A; Manosuthi W
    Southeast Asian J Trop Med Public Health; 2011 May; 42(3):651-8. PubMed ID: 21706943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-tuberculous drug induced liver injury - Do we need to rethink?
    Pandey J; Madaan P; Saini L; Verma S
    Indian J Tuberc; 2020 Apr; 67(2):260-261. PubMed ID: 32553322
    [No Abstract]   [Full Text] [Related]  

  • 40. Isoniazid hepatotoxicity associated with treatment of latent tuberculosis infection: a 7-year evaluation from a public health tuberculosis clinic.
    Fountain FF; Tolley E; Chrisman CR; Self TH
    Chest; 2005 Jul; 128(1):116-23. PubMed ID: 16002924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.